This work is licensed under the Creative Commons Attribution 4.0 International License.
Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 1967;215:58-59.BlaschkoHComlineRSSchneiderFHSilverMSmithADSecretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulationNature1967215585910.1038/215058a0Search in Google Scholar
Winkler H, Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 1992;49:497-528.WinklerHFischer-ColbrieRThe chromogranins A and B: the first 25 years and future perspectivesNeuroscience19924949752810.1016/0306-4522(92)90222-NSearch in Google Scholar
Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SR. The extended granin family: structure, function, and biomedical implications. Endocr Rev. 2011;32:755-797.BartolomucciAPossentiRMahataSKFischer-ColbrieRLohYPSaltonSRThe extended granin family: structure, function, and biomedical implicationsEndocr Rev20113275579710.1210/er.2010-0027359167521862681Search in Google Scholar
O’Connor DT, Burton D, Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab. 1983;57:1084-1086.O’ConnorDTBurtonDDeftosLJ.Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissuesJ Clin Endocrinol Metab1983571084108610.1210/jcem-57-5-10846352725Search in Google Scholar
Lloyd RV, Hawkins K, Jin L, Kulig E, Fields K. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen. Lab Invest. 1992;67:394-404.LloydRVHawkinsKJinLKuligEFieldsKChromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammalsRegulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen. Lab Invest199267394404Search in Google Scholar
Piotrowska Ż, Janiuk I, Lewandowska A, Kasacka I. Renovascular hypertensive decrease immunoreactivity of cells containing chromogranin A and pancreastatin in the pancreas of rats. Histol Histopathol. 2017;32:69-75.PiotrowskaŻJaniukILewandowskaAKasackaI.Renovascular hypertensive decrease immunoreactivity of cells containing chromogranin A and pancreastatin in the pancreas of ratsHistol Histopathol2017326975Search in Google Scholar
Helman LJ, Gazdar AF, Park J-G, Cohen PS, Cotelingam JD, Israel MA. Chromogranin A expression in normal and malignant human tissues. J Clin Invest. 1988;82:686-690.HelmanLJGazdarAFParkJ-GCohenPSCotelingamJDIsraelMAChromogranin A expression in normal and malignant human tissuesJ Clin Invest19888268669010.1172/JCI1136483035643403722Search in Google Scholar
Bandyopadhyay GK, Mahata SK. Chromogranin A regulation of obesity and peripheral insulin sensitivity. Front Endocrinol (Lausanne) 2017;8:20.BandyopadhyayGKMahataSKChromogranin A regulation of obesity and peripheral insulin sensitivityFront Endocrinol (Lausanne)201782010.3389/fendo.2017.00020529632028228748Search in Google Scholar
Corti A, Marcucci F, Bachetti T. Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers. Pflugers Arch. 2018;470:199-210.CortiAMarcucciFBachettiTCirculating chromogranin A and its fragments as diagnostic and prognostic disease markersPflugers Arch201847019921010.1007/s00424-017-2030-y29018988Search in Google Scholar
Sánchez-Margalet V, González-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes. Am J Physiol. 1998;275:E1055-E1060.Sánchez-MargaletVGonzález-YanesC.Pancreastatin inhibits insulin action in rat adipocytesAm J Physiol1998275E1055E106010.1152/ajpendo.1998.275.6.E10559843749Search in Google Scholar
Wollam J, Mahata S, Riopel M, Hernandez-Carretero A, Biswas A, Bandyopadhyay GK, Chi NW, Eiden LE, Mahapatra NR, Corti A, Webster NJG, Mahata SK. Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion. Cell Tissue Res. 2017;368:487-501.WollamJMahataSRiopelMHernandez-CarreteroABiswasABandyopadhyayGKChiNWEidenLEMahapatraNRCortiAWebsterNJGMahataSKChromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretionCell Tissue Res201736848750110.1007/s00441-017-2580-528220294Search in Google Scholar
Broedbaek K, Hilsted L. Chromogranin A as biomarker in diabetes. Biomark Med. 2016;10:1181-1189.BroedbaekKHilstedLChromogranin A as biomarker in diabetesBiomark Med2016101181118910.2217/bmm-2016-009127611656Search in Google Scholar
Florio P, Mezzesimi A, Turchetti V, Severi FM, Ticconi C, Forconi S, Petraglia F. High levels of human chromogranin A in umbilical cord plasma and amniotic fluid at parturition. J Soc Gynecol Investig. 2002;9:32-36.FlorioPMezzesimiATurchettiVSeveriFMTicconiCForconiSPetragliaFHigh levels of human chromogranin A in umbilical cord plasma and amniotic fluid at parturitionJ Soc Gynecol Investig20029323610.1177/107155760200900107Search in Google Scholar
Syversen U, Opsjøn SL, Stridsberg M, Sandvik AK, Dimaline R, Tingulstad S, Arntzen KJ, Brenna E, Waldum HL. Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies. J Clin Endocrinol Metab. 1996;81:4470-4475.SyversenUOpsjønSLStridsbergMSandvikAKDimalineRTingulstadSArntzenKJBrennaEWaldumHLChromogranin A and pancreastatin-like immunoreactivity in normal pregnanciesJ Clin Endocrinol Metab19968144704475Search in Google Scholar
Tsubouchi H, Nakai Y, Toda M, Morimoto K, Chang YS, Ushioda N, Kaku S, Nakamura T, Kimura T, Shimoya K. Change of salivary stress marker concentrations during pregnancy: maternal depressive status suppresses changes of those levels. J Obstet Gynaecol Res. 2011;37:1004-1009.TsubouchiHNakaiYTodaMMorimotoKChangYSUshiodaNKakuSNakamuraTKimuraTShimoyaKChange of salivary stress marker concentrations during pregnancy: maternal depressive status suppresses changes of those levelsJ Obstet Gynaecol Res2011371004100910.1111/j.1447-0756.2010.01473.x21463431Search in Google Scholar
Moftaquir-Handaj A, Barbé F, Barbarino-Monnier P, Aunis D, Boutroy MJ. Circulating chromogranin A and catecholamines in human fetuses at uneventful birth. Pediatr Res. 1995;37:101-105.Moftaquir-HandajABarbéFBarbarino-MonnierPAunisDBoutroyMJ.Circulating chromogranin A and catecholamines in human fetuses at uneventful birthPediatr Res19953710110510.1203/00006450-199501000-000197700724Search in Google Scholar
Van Reempts PJ, Wouters AN, Laroche S, Pinxteren J, De Potter W, Vanderauwera JC, Van Acker KJ. Umbilical cord dopamine beta-hydroxylase, chromogranin A and met-enkephalin after conditions associated with chronic intrauterine stress. Biol Neonate 1996;69:22-29.VanReempts PJWoutersANLarocheSPinxterenJDe PotterWVanderauweraJCVanAcker KJUmbilical cord dopamine beta-hydroxylase, chromogranin A and met-enkephalin after conditions associated with chronic intrauterine stressBiol Neonate199669222910.1159/0002442748777245Search in Google Scholar
Schneider H. Placental dysfunction as a key element in the pathogenesis of preeclampsia. Dev Period Med. 2017;21:163-170.SchneiderHPlacental dysfunction as a key element in the pathogenesis of preeclampsiaDev Period Med201721163170Search in Google Scholar
Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195:40-49.NessRBSibaiBMShared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsiaAm J Obstet Gynecol2006195404910.1016/j.ajog.2005.07.04916813742Search in Google Scholar
Jauniaux E, Burton GJ. Pathophysiology of histological changes in early pregnancy loss. Placenta 2005;26:114-123.JauniauxEBurtonGJPathophysiology of histological changes in early pregnancy lossPlacenta20052611412310.1016/j.placenta.2004.05.01115708112Search in Google Scholar
Nicol L, McNeilly JR, Stridsberg M, Crawford JL, McNeilly AS. Influence of steroids and GnRH on biosynthesis and secretion of secretogranin II and chromogranin A in relation to LH release in LβT2 gonadotroph cells. J Endocrinol. 2002;174:473-483.NicolLMcNeillyJRStridsbergMCrawfordJLMcNeillyASInfluence of steroids and GnRH on biosynthesis and secretion of secretogranin II and chromogranin A in relation to LH release in LβT2 gonadotroph cellsJ Endocrinol200217447348310.1677/joe.0.174047312208668Search in Google Scholar
Zhao E, McNeilly JR, McNeilly AS, Fischer-Colbrie R, Basak A, Seong JY, Trudeau VL. Secretoneurin stimulates the production and release of luteinizing hormone in mouse LβT2 gonadotropin cells. Am J Physiol Endocrinol Metab. 2011;301:E288-E297.ZhaoEMcNeillyJRMcNeillyASFischer-ColbrieRBasakASeongJYTrudeauVLSecretoneurin stimulates the production and release of luteinizing hormone in mouse LβT2 gonadotropin cellsAm J Physiol Endocrinol Metab2011301E288E29710.1152/ajpendo.00070.2011315453221521715Search in Google Scholar
Matsumoto T, Asakura H, Hayashi T. Increased salivary chromogranin A in women with severe negative mood states in the premenstrual phase. J Psychosom Obstet Gynaecol. 2012;33:120-128.MatsumotoTAsakuraHHayashiTIncreased salivary chromogranin A in women with severe negative mood states in the premenstrual phaseJ Psychosom Obstet Gynaecol20123312012810.3109/0167482X.2012.69749822779913Search in Google Scholar
Tamura T, Jobo T, Watanabe J, Kanai T, Kuramoto H. Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium. Int J Gynecol Cancer 2006;16:821-826.TamuraTJoboTWatanabeJKanaiTKuramotoHNeuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometriumInt J Gynecol Cancer20061682182610.1111/j.1525-1438.2006.00419.x16681768Search in Google Scholar